Robbie Marcus
Stock Analyst at JP Morgan
(4.04)
# 404
Out of 4,814 analysts
154
Total ratings
53.77%
Success rate
8.69%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Downgrades: Underweight | $40 → $17 | $14.44 | +17.73% | 5 | Apr 4, 2025 | |
| MMSI Merit Medical Systems | Initiates: Overweight | $120 | $90.82 | +32.14% | 1 | Mar 28, 2025 | |
| COO The Cooper Companies | Maintains: Overweight | $120 → $110 | $79.55 | +38.28% | 4 | Mar 7, 2025 | |
| BAX Baxter International | Maintains: Neutral | $38 → $36 | $28.89 | +24.61% | 17 | Feb 21, 2025 | |
| CNMD CONMED | Downgrades: Neutral | $85 → $70 | $48.54 | +44.21% | 6 | Feb 6, 2025 | |
| SYK Stryker | Maintains: Overweight | $420 → $445 | $346.60 | +28.39% | 9 | Jan 29, 2025 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $575 → $675 | $482.40 | +39.93% | 5 | Jan 24, 2025 | |
| NPCE NeuroPace | Maintains: Overweight | $9 → $14 | $10.80 | +29.63% | 4 | Dec 17, 2024 | |
| BVS Bioventus | Upgrades: Neutral | $12 → $13 | $7.81 | +66.56% | 3 | Dec 17, 2024 | |
| ZBH Zimmer Biomet Holdings | Upgrades: Overweight | $125 → $128 | $97.88 | +30.77% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $95.25 | +15.49% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $246.95 | +33.63% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $32 | $14.86 | +115.34% | 1 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $31.65 | +26.38% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $78 | $71.56 | +9.01% | 4 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $75 → $85 | $68.61 | +23.89% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $62.37 | +44.30% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $31.89 | +56.79% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $6.46 | +23.84% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $36 → $13 | $6.25 | +108.00% | 5 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $277.77 | -10.00% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $16 | $9.41 | +70.03% | 3 | Dec 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $6.88 | +1.74% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $340 → $181 | $150.00 | +20.67% | 4 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $56 → $43 | $15.80 | +172.15% | 5 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $17 | $12.07 | +40.85% | 2 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $129.70 | -9.02% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $100.96 | +54.52% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $130 → $105 | $82.70 | +26.96% | 11 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $90.07 | -55.59% | 2 | May 5, 2020 |
RxSight
Apr 4, 2025
Downgrades: Underweight
Price Target: $40 → $17
Current: $14.44
Upside: +17.73%
Merit Medical Systems
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $90.82
Upside: +32.14%
The Cooper Companies
Mar 7, 2025
Maintains: Overweight
Price Target: $120 → $110
Current: $79.55
Upside: +38.28%
Baxter International
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $28.89
Upside: +24.61%
CONMED
Feb 6, 2025
Downgrades: Neutral
Price Target: $85 → $70
Current: $48.54
Upside: +44.21%
Stryker
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $346.60
Upside: +28.39%
Intuitive Surgical
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $482.40
Upside: +39.93%
NeuroPace
Dec 17, 2024
Maintains: Overweight
Price Target: $9 → $14
Current: $10.80
Upside: +29.63%
Bioventus
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $7.81
Upside: +66.56%
Zimmer Biomet Holdings
Dec 17, 2024
Upgrades: Overweight
Price Target: $125 → $128
Current: $97.88
Upside: +30.77%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $95.25
Upside: +15.49%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $246.95
Upside: +33.63%
Nov 5, 2024
Initiates: Overweight
Price Target: $32
Current: $14.86
Upside: +115.34%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $31.65
Upside: +26.38%
Oct 25, 2024
Maintains: Neutral
Price Target: $72 → $78
Current: $71.56
Upside: +9.01%
Oct 25, 2024
Maintains: Neutral
Price Target: $75 → $85
Current: $68.61
Upside: +23.89%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $62.37
Upside: +44.30%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $31.89
Upside: +56.79%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $6.46
Upside: +23.84%
May 1, 2024
Downgrades: Neutral
Price Target: $36 → $13
Current: $6.25
Upside: +108.00%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $277.77
Upside: -10.00%
Dec 20, 2023
Maintains: Neutral
Price Target: $10 → $16
Current: $9.41
Upside: +70.03%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $6.88
Upside: +1.74%
Oct 17, 2023
Maintains: Overweight
Price Target: $340 → $181
Current: $150.00
Upside: +20.67%
May 24, 2023
Downgrades: Underweight
Price Target: $56 → $43
Current: $15.80
Upside: +172.15%
Feb 23, 2023
Maintains: Neutral
Price Target: $15 → $17
Current: $12.07
Upside: +40.85%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $129.70
Upside: -9.02%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $100.96
Upside: +54.52%
Dec 17, 2021
Downgrades: Neutral
Price Target: $130 → $105
Current: $82.70
Upside: +26.96%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $90.07
Upside: -55.59%